Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
September 21 2017 - 10:30AM
Business Wire
Pfizer Inc. invites investors and the general public to listen
to a discussion with Liz Barrett, Global President, Oncology, and
Chris Boshoff, Senior Vice President and Head, Immuno-Oncology,
Early Development and Translational Oncology, at the LEERINK
Partners Roundtable Series: Rare Disease and Immuno-Oncology on
Thursday, September 28, 2017 at 9:00 a.m. Eastern Daylight
Time.
To listen to the webcast, visit our web site at
www.pfizer.com/investors. Information on accessing and
pre-registering for the webcast will be available at
www.pfizer.com/investors beginning today.
Visitors will be able to listen to an archived copy of the
webcast at www.pfizer.com/investors.
Disclosure Notice: The webcast may include
forward-looking statements about, among other things, our
anticipated future operating and financial performance, business
plans and prospects, in-line products and product candidates,
strategic reviews, capital allocation, business-development plans,
the benefits expected from our business development transactions
and plans relating to share repurchases and dividends that are
subject to substantial risks and uncertainties that could cause
actual results to differ materially from those expressed or implied
by such statements. A description of these risks and uncertainties
can be found in Pfizer’s Annual Report on Form 10-K for the fiscal
year ended December 31, 2016 and in its subsequent reports on Form
10-Q, including in the sections thereof captioned “Risk Factors”
and “Forward-Looking Information and Factors That May Affect Future
Results”, as well as in its subsequent reports on Form 8-K, all of
which are filed with the U.S. Securities and Exchange Commission
and available at www.sec.gov and www.pfizer.com.
The forward-looking statements in the webcast speak only as of
the original date of the webcast. Pfizer assumes no obligation to
update forward-looking statements contained in the webcast as the
result of new information or future events or developments.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170921005231/en/
For Pfizer Inc.Media:Sally Beatty, 212-733-6566orInvestors:Ryan
Crowe, 212-733-8160
Pfizer (NYSE:PFE)
Historical Stock Chart
From Aug 2024 to Sep 2024
Pfizer (NYSE:PFE)
Historical Stock Chart
From Sep 2023 to Sep 2024